Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)

SHE:002880 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	1,129	1,193	1,020	659.82	894.22	894.11
Other Revenue	10.54	10.54	28.96	8.12	13.21	10.46
Revenue	1,140	1,203	1,049	667.93	907.43	904.56
Revenue Growth (YoY)	-2.33%	14.75%	56.98%	-26.39%	0.32%	10.12%
Cost of Revenue	656.81	699.32	615.26	427.02	536.52	568.22
Gross Profit	483.18	503.87	433.24	240.91	370.91	336.35
Selling, General & Admin	125.9	121.81	126.94	91.67	88.45	81.6
Research & Development	46.58	49.05	63.62	35.87	47.59	45.1
Other Operating Expenses	4.47	5.16	3.25	-1.73	7.36	6.25
Operating Expenses	194.75	180.1	191.31	124.47	144.51	131.57
Operating Income	288.43	323.76	241.93	116.44	226.4	204.78
Interest Expense	-21.49	-21.93	-14.34	-2.06	-1.87	-1.06
Interest & Investment Income	10.13	7.92	8.03	8.85	8.91	8.36
Other Non Operating Income (Expenses)	-1.06	-1.81	-0.94	-1.62	-1.15	-0.13
EBT Excluding Unusual Items	276.01	307.95	234.68	121.62	232.29	211.96
Gain (Loss) on Sale of Investments	-13.93	-14.05	2.23	14.33	0.74	-
Gain (Loss) on Sale of Assets	0.16	0.21	0.06	0.04	-	0.07
Asset Writedown	-0.06	-0.06	-0.16	-0.5	-	-0.58
Other Unusual Items	2.02	2.69	8.65	1.84	8.15	7.59
Pretax Income	264.2	296.74	245.45	137.32	241.17	219.04
Income Tax Expense	34.95	42.78	27.91	16.1	36.18	29.46
Earnings From Continuing Operations	229.25	253.96	217.54	121.21	204.99	189.59
Minority Interest in Earnings	-0.57	-0.44	1.11	-3.69	0.44	0.81
Net Income	228.68	253.52	218.65	117.52	205.44	190.4
Net Income to Common	228.68	253.52	218.65	117.52	205.44	190.4
Net Income Growth	-8.57%	15.95%	86.06%	-42.80%	7.90%	11.12%
Shares Outstanding (Basic)	227	227	227	227	227	227
Shares Outstanding (Diluted)	227	227	227	227	227	227
Shares Change (YoY)	0.02%	0.00%	0.01%	-0.01%	0.00%	0.00%
EPS (Basic)	1.01	1.12	0.96	0.52	0.91	0.84
EPS (Diluted)	1.01	1.12	0.96	0.52	0.91	0.84
EPS Growth	-8.59%	15.94%	86.05%	-42.79%	7.90%	11.12%
Free Cash Flow	-28.74	-77.73	69.08	-326.17	6.06	114.76
Free Cash Flow Per Share	-0.13	-0.34	0.30	-1.44	0.03	0.51
Dividend Per Share	0.200	0.200	0.400	-	0.200	0.179
Dividend Growth	-	-50.00%	-	-	11.98%	17.19%
Gross Margin	42.38%	41.88%	41.32%	36.07%	40.88%	37.18%
Operating Margin	25.30%	26.91%	23.07%	17.43%	24.95%	22.64%
Profit Margin	20.06%	21.07%	20.85%	17.59%	22.64%	21.05%
Free Cash Flow Margin	-2.52%	-6.46%	6.59%	-48.83%	0.67%	12.69%
EBITDA	426.15	439.43	328.19	180.64	280.85	250.5
EBITDA Margin	37.38%	36.52%	31.30%	27.05%	30.95%	27.69%
D&A For EBITDA	137.73	115.67	86.26	64.2	54.45	45.72
EBIT	288.43	323.76	241.93	116.44	226.4	204.78
EBIT Margin	25.30%	26.91%	23.07%	17.43%	24.95%	22.64%
Effective Tax Rate	13.23%	14.42%	11.37%	11.73%	15.00%	13.45%
Revenue as Reported	1,140	1,203	1,049	667.93	907.43	904.56
Advertising Expenses	-	0.31	0.45	0.28	0.18	0.34

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.